ARCHIVES

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

This article is from The Cancer Letter archive.

Vol. 26 No. 37 | October 13, 2000

Download PDF Visit The Full Archive

Related Articles

NCI advisory Group, Other Cancer Meetings

March 29, 1985

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

December 14, 2001

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

Partial Responses To Zactima In Thyroid Cancer Trial

January 27, 2006